Use of Bowman's membrane electrocautery in blind eyes with painful bullous keratopathy not amenable to corneal transplantation: a retrospective case series.

Abstract

This study evaluated the safety and efficacy of Bowman's membrane electrocautery in blind painful eyes with bullous keratopathy not amenable to corneal transplantation. Eleven eyes of 11 subjects with painful bullous keratopathy and poor visual potential who underwent electrocautery of Bowman's membrane at a tertiary referral ophthalmology clinic were reviewed retrospectively. Subject demographics and preoperative and postoperative data were collected, including description of pain, slit lamp biomicroscopy, best corrected visual acuity, topical medication use, and complications. Efficacy of the procedure on pain reduction, bullae resolution, and topical medication use were assessed at post-operative visits. Safety was also evaluated based on any complications. Bowman's membrane electrocautery effectively resolved bullae in all eyes examined up to 6months postoperatively; however, 2 eyes had recurrence by 1year. Mean age at the time of surgery was 69.8years and mean duration of follow-up was 15.4months. Pain reduction was achieved in all eyes at 1month, but 1 subject had pain recurrence by 6months and another by 1year. The median number of drops per day decreased from 6 preoperatively to 1.7 at 6months. Two subjects who had underlying advanced ophthalmic disease had a mild reduction in vision. Bowman's membrane electrocautery is a safe and minimally invasive procedure for the management of painful bullous keratopathy in eyes with low vision potential and not amenable to corneal transplantation. Duration of effect appears to last at least 6months and up to 3years post-procedure.